Literature DB >> 14665474

Pulmonary cryptococcosis in normal hosts: treat or observe?

Judith A Aberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14665474     DOI： 10.1378/chest.124.6.2049

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  The RGS protein Crg2 is required for establishment and progression of murine pulmonary cryptococcosis.

Authors:  Amy Whittington; Ping Wang
Journal:  Med Mycol       Date:  2010-09-06       Impact factor: 4.076

2.  Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis.

Authors:  Kaixiong Liu; Haibo Ding; Bing Xu; Ruixiong You; Zhen Xing; Jianfeng Chen; Qichang Lin; Jieming Qu
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda.

Authors:  Samuel Deok-jong Yoo; William Worodria; J L Davis; Adithya Cattamanchi; Saskia den Boon; Rachel Kyeyune; Harriet Kisembo; Laurence Huang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

4.  Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.

Authors:  J W Baddley; J R Perfect; R A Oster; R A Larsen; G A Pankey; H Henderson; D W Haas; C A Kauffman; R Patel; A K Zaas; P G Pappas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

Review 5.  Clinicopathological features of isolated pulmonary cryptococcosis in HIV-negative patients.

Authors:  Huan-Huan Wu; Yan-Xiao Chen; Shuang-Yan Fang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Postoperative Antifungal Treatment of Pulmonary Cryptococcosis in Non-HIV-Infected and Non-Transplant-Recipient Patients: A Report of 110 Cases and Literature Review.

Authors:  Shuo Wei; Xin Su; Yun-Hu Pan; Yuan-Yuan Zheng; Xiao-Wen Dong; Xiao-Hua Hu; Fan Wu; Yi Shi
Journal:  Open Forum Infect Dis       Date:  2020-01-13       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.